Coherus Oncology, Inc

NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)This U.S. industry comprises establishments primarily engaged in conducting biotechnology (except nanobiotechnology) research and experimental development. Biotechnology (except nanobiotechnology) research and experimental development involves the study of the use of microorganisms and cellular and biomolecular processes to develop or alter living or non-living materials. This research and development in biotechnology (except nanobiotechnology) may result in development of new biotechnology (except nanobiotechnology) processes or in prototypes of new or genetically-altered products that may be reproduced, utilized, or implemented by various industries. Learn more at the U.S. Census Bureau
Name | Role | Address |
---|---|---|
CT CORPORATION SYSTEM | Agent | 450 VETERANS MEMORIAL PARKWAY SUITE 7A, EAST PROVIDENCE, RI, 02914, USA |
Name | Role | Address |
---|---|---|
MCDAVID STILLWELL | TREASURER | 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY, CA 94065 USA |
Name | Role | Address |
---|---|---|
CHARLES NEWTON | DIRECTOR | 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY, CA 94065 USA |
JILL O'DONNELL-TORMEY | DIRECTOR | 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY, CA 94065 USA |
KIM TZOUMAKAS | DIRECTOR | 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY, CA 94065 USA |
MATS WAHLSTROM | DIRECTOR | 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY,, CA 94065 USA |
DENNIS LANFEAR | DIRECTOR | 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY, CA 94065 USA |
LEE N. NEWCOMER | DIRECTOR | 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY, CA 94065 USA |
MARK STOPPLER | DIRECTOR | 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY,, CA 94065 USA |
ALI J SATVAT | DIRECTOR | 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY, CA 94065 USA |
Name | Role | Address |
---|---|---|
DENNIS LANFEAR | PRESIDENT | 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY, CA 94065 USA |
Type | Date | Old Value | New Value |
---|---|---|---|
Name Change | 2025-06-06 | Coherus BioSciences, Inc. | Coherus Oncology, Inc |
Number | Name | File Date |
---|---|---|
202454320950 | Annual Report | 2024-05-14 |
202332776800 | Annual Report | 2023-04-12 |
202215648840 | Annual Report | 2022-04-25 |
202191987210 | Annual Report | 2021-02-18 |
202074621550 | Application for Certificate of Authority | 2020-11-13 |
This company hasn't received any reviews.
Date of last update: 16 Jul 2025
Sources: Rhode Island Department of State